ANEMIA PREDICTS SUSTAINED VIROLOGIC RESPONSE IN CIRRHOTIC AND NON-CIRRHOTIC CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND RIBAVIRIN IN FOUR CLINICAL TRIALS

被引：0
|
作者：
Reau, N. [1 ]
Korner, E. J. [2 ]
Han, J. [2 ]
Jensen, D. M. [1 ]
机构：
[1] Univ Chicago Hosp, Ctr Liver Dis, Chicago, IL 60637 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60894-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
892
引用
收藏
页码：S367 / S367
页数：1
相关论文
共 50 条
  • [41] Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
    Davis, GL
    Wong, JB
    McHutchison, JG
    Manns, MP
    Harvey, J
    Albrecht, J
    HEPATOLOGY, 2003, 38 (03) : 645 - 652
  • [42] Rapid Virologic Response Predicts Sustained Virologic Response in Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin Therapy
    Sarwar, Shahzad
    Iqbal, Masood
    McCormick, P. Aiden
    O'Farrelly, Cliona
    Hegarty, John E.
    GASTROENTEROLOGY, 2009, 136 (05) : A836 - A837
  • [43] Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin
    Cauli, Cristiana
    Serra, Giancarlo
    Chessa, Luchino
    Balestrieri, Cinzia
    Scioscia, Rosetta
    Lai, Maria Eliana
    Farci, Patrizia
    HAEMATOLOGICA, 2006, 91 : 76 - 77
  • [44] The role of cholesterol on sustained virological response (SVR) in the treatment of genotype-1 infected hepatitis C (cHC) patients with peginterferon Alfa-2a (PEG) and ribavirin (RBV)
    Mauss, Stefan
    Zehnter, Elmar
    Hueppe, Dietrich
    Kaiser, Stephan
    Becker, Klaus
    Lutz, Thomas
    Heyne, Renate
    John, Christine
    Moog, Gero
    Schober, Andreas
    Pfaff, Rainer
    Zipf, Andreas
    Racky, Stefan A.
    Lohmeyer, Jueregn
    Bokemeyer, Bernd
    Kallinowski, Birgit
    Witthoeft, Thomas
    Alshuth, Ulrich
    GASTROENTEROLOGY, 2008, 134 (04) : A829 - A829
  • [45] Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
    Lawitz, Eric
    Lalezari, Jay P.
    Hassanein, Tarek
    Kowdley, Kris V.
    Poordad, Fred F.
    Sheikh, Aasim M.
    Afdhal, Nezam H.
    Bernstein, David E.
    DeJesus, Edwin
    Freilich, Bradley
    Nelson, David R.
    Dieterich, Douglas T.
    Jacobson, Ira M.
    Jensen, Donald
    Abrams, Gary A.
    Darling, Jama M.
    Rodriguez-Torres, Maribel
    Reddy, K. Rajender
    Sulkowski, Mark S.
    Bzowej, Natalie H.
    Hyland, Robert H.
    Ho, Hongmei
    Lin, Ming
    Mader, Michael
    Hindes, Robert
    Albanis, Efsevia
    Symonds, William T.
    Berrey, Michelle M.
    Muir, Andrew
    LANCET INFECTIOUS DISEASES, 2013, 13 (05): : 401 - 408
  • [46] A comparison of sustained viral response in patients with chronic hepatitis C virus (HCV) treated with peginterferon alfa-2a (Peg2a) versus peginterferon alfa-2b (Peg2b) and ribavirin
    Poordad, F
    Tran, TT
    Ayoub, W
    Patel, Y
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S130 - S130
  • [47] High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin
    Wirth, Stefan
    Ribes-Koninckx, Carmen
    Angeles Calzado, Maria
    Bortolotti, Flavia
    Zancan, Lucia
    Jara, Paloma
    Shelton, Mark
    Kerkar, Nanda
    Galoppo, Marcela
    Pedreira, Alejandra
    Rodriguez-Baez, Norberto
    Ciocca, Mirta
    Lachaux, Alain
    Lacaille, Florence
    Lang, Thomas
    Kullmer, Ulrike
    Huber, Wolf Dietrich
    Gonzalez, Teresita
    Pollack, Henry
    Alonso, Estella
    Broue, Pierre
    Ramakrishna, Jyoti
    Neigut, Deborah
    del Valle-Segarra, Antonio
    Hunter, Bessie
    Goodman, Zachery
    Xu, Christine R.
    Zheng, Hanzhe
    Noviello, Stephanie
    Sniukiene, Vilma
    Brass, Clifford
    Albrecht, Janice K.
    JOURNAL OF HEPATOLOGY, 2010, 52 (04) : 501 - 507
  • [48] EFFICACY OF INTERFERON-FREE THERAPY IN CIRRHOTIC AND NON-CIRRHOTIC CHRONIC HEPATITIS C PATIENTS IN CLINICAL PRACTICE
    Badia, E.
    Ramos, H.
    Linares, P.
    Martin, I.
    Almohalla, C.
    Jorquera, F.
    Garcia, I.
    Vasquez, M.
    Conde, P.
    Alvarez, B.
    Karpman, G.
    Gozalo, V.
    Lorenzo, S.
    Gomez, J.
    Joao, D.
    de Benito, M.
    Ruiz, L.
    Jimenez, F.
    Saez-Royuela, F.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S765 - S765
  • [49] Impact of Asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C
    Missiha, Sharif
    Heathcote, Jenny
    Arenovich, Tamara
    Khan, Kamran
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (10): : 2181 - 2188
  • [50] Impact of Asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C
    Missiha, SB
    Heathcote, EJ
    Arenovich, T
    Khan, K
    GASTROENTEROLOGY, 2005, 128 (04) : A683 - A684
12345